한글목차

바이러스 검체 채취 시장은 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다.

이는 면역분석법, 핵산 기반 증폭검사법, PCR 기반법, 질량분석법, NGS법 등 첨단 바이러스 검체 채취 기술이 개발되어 전 세계 다양한 바이러스 감염에 대해 정확하고 빠른 결과를 얻을 수 있게 되었기 때문으로 보입니다. 제약·바이오의약품 산업의 연구개발이 활발해짐에 따라, 또한, 신약 개발을 위한 바이오의약품에서 고분자에 대한 관심이 높아지면서 예측 기간 동안 시장 성장을 더욱 촉진할 것으로 보입니다. 마찬가지로, 검출 기술, 약물 및 백신과 같은 항바이러스 치료의 발전이 확대되면서 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

실험실 검사 증가

바이러스 검출을 위한 신속한 검사의 증가는 수년 동안 시장 성장을 촉진할 것으로 예상됩니다. 검사 결과의 정확성은 정확한 진단과 치료 방침을 결정하는 데 중요합니다. 따라서 신속 진단 검사는 처방 개선 및 입원 기간 단축과 같은 신속하고 빠른 결과를 얻기 위해 사용되어 예측 기간 동안 시장 성장을 더욱 촉진할 것입니다. 세계보건기구(WHO)가 2021년 11월 발표한 자료에 따르면, 전 세계적으로 매일 100만 명 이상의 성병(S.T.I.)이 발생하고 있습니다. 이러한 검사는 환자에게서 혈액, 소변 등의 샘플을 채취하여 특정 질병을 진단하고 가장 가능성이 높은 치료 방침을 결정하기 위해 정확한 결과를 얻기 위해 필요한 검사입니다.

바이러스성 질환의 유병률 증가와 새로운 병원균의 출현

지카 바이러스 및 바베시아 질병과 같은 바이러스성 질환의 증가는 예측 기간 동안 바이러스 검체 수집 시장의 수요를 증가시킬 것으로 보입니다. 또한, 혁신적인 바이러스 검체 채취 기술, 소모품 및 장비에 대한 수요 증가는 수년간 시장 성장을 더욱 촉진할 것으로 보입니다. 아프리카 지역의 말라리아 유행과 모기를 매개로 한 지카 바이러스 감염 가능성 등 다른 국가들은 새로운 질병과 신흥 질병을 확인하기 위해 노력하고 있으며, 그 결과 이 지역에서는 지카 바이러스 검사가 의무화되었습니다. 2021년 11월 세계보건기구(WHO)에 따르면, 2020년 말 기준 약 3,770만 명이 HIV에 감염된 것으로 추정됩니다. 이 중 3분의 2가 넘는 2,540만 명이 WHO 아프리카 지역에 거주하고 있으며, 2020년에는 약 68만 명이 HIV로 인해 사망하고 150만 명(100만-200만 명)이 HIV에 감염될 것으로 예상됩니다. 또한 세계보건기구(WHO)가 2021년 7월 발표한 자료에 따르면 2020년 매독 신규 감염자는 전 세계적으로 700만 명으로 추정됩니다. 이는 수년 동안 바이러스 검체 채취 시장의 수요를 더욱 증가시킬 것으로 예상됩니다.

사용 가능한 커스터마이징

TechSci Research는 주어진 시장 데이터를 사용하여 기업의 고유한 요구에 따라 맞춤화할 수 있는 서비스를 제공합니다. 보고서에서 다음과 같은 커스터마이징이 가능합니다.

회사 소개

• 추가 시장 진입 기업(최대 5개사)에 대한 심층 분석 및 프로파일링

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 바이러스 검체 채취 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별(바이러스 수송 매체, 검체 채취 튜브, 스왑, 채혈 키트)
  • 검체별(혈액 검체, 자궁경부 검체, 비강 검체, 비인두 검체, 인두 검체, 구강 검체, 기타 검체)
  • 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
  • 기업별(2022)
• 시장 맵
  • 제품 유형별
  • 샘플별
  • 지역별

제6장 북미의 바이러스 검체 채취 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별
  • 검체별
  • 국가별
• 북미, 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 바이러스 검체 채취 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별
  • 검체별
  • 국가별
• 유럽, 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 바이러스 검체 채취 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별
  • 검체별
  • 국가별
• 아시아태평양 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 바이러스 검체 채취 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별
  • 검체별
  • 국가별
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 바이러스 검체 채취 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별
  • 검체별
  • 국가별
• MEA : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근의 전개
• 인수합병
• 제품 발표

제13장 세계의 바이러스 검체 채취 시장, SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 상황

• Business Overview
• Product Offerings
• Recent Developments
• Financials(As Reported)
• Key Personnel
• SWOT Analysis
  • Becton, Dickinson and Company.
  • Quidel Corporation.
  • Thermo Fisher Scintific Inc.
  • Trinity Biotech PLC.
  • Titan Biotech Ltd.
  • Diasorin SA.
  • Vircell S.L.
  • Copan Italia S.P.A
  • Puritan Medical Products Co.
  • Hardy Diagnostics Inc.

제16장 전략적 제안

영문목차

Virology Specimen Collection market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the development of advanced viral specimen collection technologies such as immunoassay, nucleic acid-based amplification testing methods or PCR-based methods, mass spectrometry, and NGS methods for accurate, quick results for different viral infections across the globe. Along with the rising research and development in the pharmaceutical and biopharmaceutical industry. Also, the growing focuses on the large molecule in biopharmaceuticals for developing novel drugs will further boost the growth of the market in the forecasted period. Similarly, growing advances in anti-viral therapy in terms of detection techniques, medication, and vaccines are expected to boost the growth of the market during the forecast period.

The increasing number of laboratory tests

The increasing number of rapid tests for easy detection of viruses is expected to drive the growth of the market over the years. The accuracy of test results is important in making accurate diagnostic and therapeutic decisions. So rapid diagnostic tests are used for rapid and faster results with improving prescribed and reduced time for hospitalization which will further drive the growth of the market during the forecast period. According to the data published by the World Health Organization (WHO), in November 2021, over 1 million sexually transmitted infections (S.T.I.s) are acquired every day across the world. These tests are necessary for accurate results by the collection of blood, urine, or other samples from patients to diagnose their specific medical condition and determine the most likely course of treatment.

Also, some other important clinical laboratory tests are used for virus detection, such as clinical chemistry, hematology, D.N.A. testing, reproductive biology tests, complete blood count (C.B.C.), comprehensive metabolic panel, basic metabolic panel, liver panel, lipid panel, HbA1c, HGB/HCT, urinalysis, and thyroid-stimulating hormone. Hence, the Global Virology Specimen Collection Market will grow with different laboratory tests available, which are increasingly accepted by clinicians to navigate through highly contagious infections that include Ebola, Middle East respiratory syndrome coronavirus (MERS-CoV), and hantavirus. This is expected to enhance the usage rate of viral specimen collection products for rapid diagnostic tests across the globe in the forecast period.

Rising prevalence of viral diseases and the emergence of newer pathogens

The growing prevalence of viral diseases, such as outbreaks of the Zika virus and Babesia, will enhance the demand for the virology specimen collection market during the forecast period. Also, the growing demand for innovative virology specimen collection technology, consumables, and instruments will further drive the growth of the market over the years. Other countries have started initiatives to check for new and emerging diseases, such as the prevalence of malaria in African regions and the possibility of mosquito-borne transfer of Zika, resulting in mandates for Zika virus screening in the region. According to the World Health Organization (WHO), in November 2021, an estimated 37.7 million people were affected by H.I.V. at the end of 2020. Out of these, over two-thirds, (25.4 million) of the population were residing in the WHO African Region. In 2020, approximately 680,000 people died from HIV-related causes and 1.5 million (1.0-2.0 million) people acquired the disease. In addition, as per the data published by World Health Organization (WHO) in July 2021, there were an estimated 7 million new syphilis infections in 2020 across the globe. This, in turn, is expected to further boost the demand for the Virology Specimen Collection Market over the years.

Market Segmentation

Global Virology Specimen Collection Market can be segmented by product type, sample, and by region. Based on the product type, the market can be segmented into Viral Transport Media, Specimen Collection Tubes, Swabs, and Blood Collection Kits. Based on the sample, the market can be segmented into Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, and Other Samples. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global Virology Specimen Collection market on account of the growing well-developed laboratories in the country.

Recent Development

• In November 2020, Mybiopassport (Switzerland) launched its e-Commerce platform for online ordering of the "COVID-19 & Immunity Profile" test, an at-home blood collection test. The test helps determine if the individual has been previously infected by COVID-19 through the development of specific antibodies.
• In April 2020, the University of Rochester Medical Center Rochester (U.S.) developed a finger-stick test for detecting more than 50 strains of the flu from just a few blood drops.
• In February 2020, Thermo Fisher Scientific (U.S.) announced its collaboration with NanoPin Technologies, Inc. for developing highly sensitive liquid chromatography-mass spectrometry (LC-MS) based workflows to advance the detection technology for blood-based infectious diseases.

Market Players

Becton, Dickinson and Company, Quidel Corporation, Thermo Fisher Scintific Inc., Trinity Biotech P.L.C., Titan Biotech Ltd., Diasorin SA., Vircell S.L., Copan Italia S.P.A., Puritan Medical Products Co., Hardy Diagnostics Inc are some of the leading players operating in the Global Virology Specimen Collection Market.

Report Scope

In this report, global Virology Specimen Collection market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below,

Virology Specimen Collection Market, By Product Type:

• Viral Transport Media
• Specimen Collection Tubes
• Swabs
• Blood Collection Kits

Virology Specimen Collection Market, By Sample:

• Blood Samples
• Cervical Samples
• Nasal Samples
• Nasopharyngeal Samples
• Throat Samples
• Oral Samples
• Other Samples

Virology Specimen Collection Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • U.A.E.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Virology Specimen Collection Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report,

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virology Specimen Collection Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 5.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Product Type
  • 5.3.2 By Sample
  • 5.3.3 By Region

6. North America Virology Specimen Collection Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 6.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 6.2.3. By Country
• 6.3. North America, Country Analysis
  • 6.3.1. United States Virology Specimen Collection Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Sample
  • 6.3.2. Canada Virology Specimen Collection Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Sample
  • 6.3.3. Mexico Virology Specimen Collection Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Sample

7. Europe Virology Specimen Collection Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 7.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 7.2.3. By Country
• 7.3. Europe, Country Analysis
  • 7.3.1. France Virology Specimen Collection Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Sample
  • 7.3.2. Germany Virology Specimen Collection Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Sample
  • 7.3.3. United Kingdom Virology Specimen Collection Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Sample
  • 7.3.4. Italy Virology Specimen Collection Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Sample
  • 7.3.5. Spain Virology Specimen Collection Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Sample

8. Asia-Pacific Virology Specimen Collection Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 8.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Virology Specimen Collection Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Sample
  • 8.3.2. India Virology Specimen Collection Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Sample
  • 8.3.3. Japan Virology Specimen Collection Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Sample
  • 8.3.4. South Korea Virology Specimen Collection Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Sample
  • 8.3.5. Australia Virology Specimen Collection Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Sample

9. South America Virology Specimen Collection Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 9.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Virology Specimen Collection Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Sample
  • 9.3.2. Argentina Virology Specimen Collection Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Sample
  • 9.3.3. Colombia Virology Specimen Collection Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Sample

10. Middle East and Africa Virology Specimen Collection Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
  • 10.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Virology Specimen Collection Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Sample
  • 10.3.2. Saudi Arabia Virology Specimen Collection Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Sample
  • 10.3.3. UAE Virology Specimen Collection Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Sample

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Virology Specimen Collection Market, SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Becton, Dickinson and Company.
  • 15.6.2 Quidel Corporation.
  • 15.6.3 Thermo Fisher Scintific Inc.
  • 15.6.4 Trinity Biotech PLC.
  • 15.6.5 Titan Biotech Ltd.
  • 15.6.6 Diasorin SA.
  • 15.6.7 Vircell S.L.
  • 15.6.8 Copan Italia S.P.A
  • 15.6.9 Puritan Medical Products Co.
  • 15.6.10 Hardy Diagnostics Inc.

16. Strategic Recommendations